Recent findings on the anticancer potential of coumarin hybrid derivatives
Paper Details
Recent findings on the anticancer potential of coumarin hybrid derivatives
Abstract
Coumarin derivatives have attracted substantial scientific interest due to their broad therapeutic potential in the field of oncology research due to their anticancer potential. Both naturally occurring and synthetically modified coumarins possess diverse pharmacological activities, and evidence highlights their strong anticancer properties. Studies emphasize the importance of understanding molecular mechanisms and structural interactions that govern the biological actions of coumarin hybrids, as these insights are crucial for optimizing their therapeutic efficacy in term of treatment. Coumarin-based hybrid compounds demonstrate the ability to modulate multiple cellular signalling pathways critical for cancer progression, including those regulating apoptosis, angiogenesis, oxidative stress, and uncontrolled cell division. Mechanistic studies show that many coumarin hybrids effectively induce apoptosis through mitochondrial disruption, caspase activation, and modulation of pro and anti-apoptotic proteins. Additionally, several derivatives exhibit potent anti-angiogenic activity by inhibiting VEGF-mediated signaling, thereby limiting tumor vascularization and growth. Their capacity to interfere with cell cycle regulators, such as cyclins and CDKs, further contributes to their antiproliferative effects. The multitargeted nature of these molecular interactions highlights the therapeutic versatility of coumarin hybrids. Overall, the emerging preclinical evidence positions coumarin derivatives as promising lead compounds for anticancer drug development, warranting further investigation through advanced pharmacological, structural, and clinical studies.
Altemimi A. 2018. Secondary metabolites: Secondary metabolic products consisting of C and H; C, H, and O; N, S, and P elements; and O/N heterocycles. In Atlas of medicinal plants and their extracts 2(74), 165–309. https://doi.org/10.1007/978-3-319-92387-1_3
Abdizadeh T, Kalantari M, Ezzatzadeh E, Mahdavi M, Foroumadi A, Shafiee A. 2017. Design, synthesis and biological evaluation of novel coumarin-based benzamides as potent histone deacetylase inhibitors and anticancer agents. European Journal of Medicinal Chemistry 132, 42–62. https://doi.org/10.1016/J.EJMECH.2017.03.024
Ahmed EY, Abdel Latif NA, El-Mansy MF, Elserwy WS, Abdelhafez OM. 2020. VEGFR-2 inhibiting effect and molecular modeling of newly synthesized coumarin derivatives as anti-breast cancer agents. Bioorganic and Medicinal Chemistry 28(5), 115328. https://doi.org/10.1016/J.BMC.2020.115328
Akram M, Iqbal M, Daniyal M, Khan AU. 2017. Awareness and current knowledge of breast cancer. Biological Research 50(1), 33. https://doi.org/10.1186/S40659-017-0140-9
Al-Wahaibi LH, Abu-Melha HM, Ibrahim DA. 2018. Synthesis of novel 1,2,4-triazolyl coumarin derivatives as potential anticancer agents. Journal of Chemistry 2018(1), 5201374. https://doi.org/10.1155/2018/5201374
Angelova VT, Vassilev NG, Vasileva-Tonkova E, Momekov G, Ivanov IC. 2016. Antiproliferative and antioxidative effects of novel hydrazone derivatives bearing coumarin and chromene moiety. Medicinal Chemistry Research 25(9), 2082–2092. https://doi.org/10.1007/S00044-016-1661-4
Arvas B, Yılmaz B, Korkmaz N, Çelik M, Şahin E. 2024. Synthesis of novel coumarin-triazole hybrids and first evaluation of the 4-phenyl substituted hybrid loaded PLGA nanoparticles delivery system to the anticancer activity. Nanotechnology 35(30), 305602.
Augsten LV, Tavares MT, de Souza MVN, Ferreira VF, Cunha AC. 2023. Antiproliferative activity and toxicity evaluation of 1,2,3-triazole and 4-methyl coumarin hybrids in the MCF7 breast cancer cell line. RSC Medicinal Chemistry 14(5), 869–879. https://doi.org/10.1039/D3MD00031A
Awaad AS. 2018. Biological activities and medicinal applications of coumarins and their derivatives. Pharmacognosy Reviews 12(24), 123–132. https://doi.org/10.4103/phrev.phrev_22_18
Ayati A, Emami S, Asadipour A, Shafiee A, Foroumadi A. 2018. Synthesis and biological evaluation of new coumarins bearing 2,4-diaminothiazole-5-carbonyl moiety. European Journal of Medicinal Chemistry 155, 483–491. https://doi.org/10.1016/J.EJMECH.2018.06.015
Basavaiah D, Veeraraghavaiah G. 2012. The Baylis–Hillman reaction: A novel concept for creativity in chemistry. Chemical Society Reviews 41, 68–78. https://doi.org/10.1039/c1cs15174f
Batran RZ, Ahmed EY, Awad HM, Ali KA, Abdel Latif NA. 2023. EGFR and PI3K/m-TOR inhibitors: Design, microwave assisted synthesis and anticancer activity of thiazole–coumarin hybrids. RSC Advances 13(42), 29070–29085. https://doi.org/10.1039/D3RA03483F
Berrino E. 2020. Carbonic anhydrase inhibitors: Versatile agents for the treatment of human diseases. PhD thesis.
Bistrović A, Krstulović L, Harej A, Grbčić P, Sedić M, Pavelić SK. 2018. Small molecule purine and pseudopurine derivatives: Synthesis, cytostatic evaluations and investigation of growth inhibitory effect in non-small cell lung cancer A549. Journal of Enzyme Inhibition and Medicinal Chemistry 33(1), 271–285. https://doi.org/10.1080/14756366.2017.1414807
Bizuayehu HM, Bray F, Ferlay J, Laversanne M, Soerjomataram I. Global burden of 34 cancers among women in 2020 and projections to 2040: Population-based data from 185 countries/territories. International Journal of Cancer 154(8), 1377–1393. https://doi.org/10.1002/IJC.34809
Bondock S, Fadaly W, Metwally MA. 2023. Design, synthesis, cytotoxic evaluation and molecular docking of novel 1,3,4-thiadiazole sulfonamides with azene and coumarin moieties as carbonic anhydrase inhibitors. Arabian Journal of Chemistry 16(8), 104956. https://doi.org/10.1016/J.ARABJC.2023.104956
Borges F, Roleira F, Milhazes N, Santana L, Uriarte E. 2005. Simple coumarins and analogues in medicinal chemistry: Occurrence, synthesis and biological activity. Current Medicinal Chemistry 12(8), 887–916.
Budzowska M, Kanaar R. 2009. Mechanisms of dealing with DNA damage-induced replication problems. Cellular and Molecular Biology Letters 53(1), 17–31. https://doi.org/10.1007/S12013-008-9039-Y
Cao D, Liu Y, Yan W, Wang Y, Zhao Y, Liu J. 2016. Design, synthesis, and evaluation of in vitro and in vivo anticancer activity of 4-substituted coumarins: A novel class of potent tubulin polymerization inhibitors. Journal of Medicinal Chemistry 59(12), 5721–5739. https://doi.org/10.1021/ACS.JMEDCHEM.6B00158
Cao D, Liu Y, Wang Y, Zhao Y, Liu J. 2019. Design and synthesis of 3-(N-substituted)aminocoumarins as anticancer agents from 3-bromopeuruthenicin. ChemistrySelect 4(34), 10197–10201. https://doi.org/10.1002/SLCT.201901377
Carey FA, Sundberg RJ. 2007. Advanced organic chemistry: Part B – reactions and synthesis. Springer.
Chougala BM, Samundeeswari S, Holiyachi M, Shastri LA, Dodamani S, Jalalpure S. 2017. Microwave synthesis of coumarinyl substituted pyridine derivatives as potent anticancer agents and molecular docking studies. ChemistrySelect 2(18), 5234–5242. https://doi.org/10.1002/SLCT.201700358
Cozzini P, Kellogg GE, Spyrakis F, Abraham DJ, Costantino G, Emerson A, Fanelli F, Gohlke H, Kuhn LA, Morris GM, Orozco M, Pertusi DA, Rizzi A, Sotriffer CA, Vallone B. 2008. Target flexibility: An emerging consideration in drug discovery and design. Journal of Medicinal Chemistry 51(20), 6237–6255. https://doi.org/10.1021/JM800562D
De Araújo RS, Guerra FQ, De Queiroz AC. 2013. Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity. International Journal of Molecular Sciences 14(1), 1293–1309.
Dhawan S, Kumar S, Sharma PK, Kumar V, Narasimhan B. 2018. Synthesis, computational studies and antiproliferative activities of coumarin-tagged 1,3,4-oxadiazole conjugates against MDA-MB-231 and MCF-7 human breast cancer cells. Bioorganic and Medicinal Chemistry 26(21), 5612–5623. https://doi.org/10.1016/J.BMC.2018.10.006
Dhawan S, Kumar S, Sharma PK, Narasimhan B. 2020. Synthesis, cytotoxicity and antimicrobial evaluation of new coumarin-tagged β-lactam triazole hybrid. Chemistry and Biodiversity 17(1), e1900462. https://doi.org/10.1002/CBDV.201900462
Durgapal SDz, Soman SS. 2019. Evaluation of novel coumarin-proline sulfonamide hybrids as anticancer and antidiabetic agents. Synthetic Communications 49(21), 2869–2883. https://doi.org/10.1080/00397911.2019.1647439
Durgapal SD, Soni R, Umar S, Suresh B, Soman SS. 2017. Anticancer activity and DNA binding studies of novel 3,7-disubstituted benzopyrones. ChemistrySelect 2(1), 147–153.
El-Agrody AM, Al-Omar MA, Amr AE, Abdalla MM, Alsharif MA. 2020. In vitro anticancer activity of pyrano[3,2-c]chromene derivatives with both cell cycle arrest and apoptosis induction. Medicinal Chemistry Research 29(4), 617–629. https://doi.org/10.1007/S00044-019-02494-3
El-Naggar AM, Hemdan MM, Atta-Allah SR. 2017. An efficient one-pot synthesis of new coumarin derivatives as potent anticancer agents under microwave irradiation. Journal of Heterocyclic Chemistry 54(6), 3519–3526. https://doi.org/10.1002/JHET.2975
El-Sayed WA, Alminderej FM, Mounier MM, Nossier ES, Saleh SM, Kassem AF. 2022. New 1,2,3-triazole-coumarin-glycoside hybrids and their 1,2,4-triazolyl thioglycoside analogs targeting mitochondria apoptotic pathway: Synthesis, anticancer activity and docking simulation. Molecules 27(17), 5688. https://doi.org/10.3390/MOLECULES27175688
Elshemy HAH, Zaki MA. 2017. Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action. Bioorganic and Medicinal Chemistry 25(3), 1066–1075. https://doi.org/10.1016/J.BMC.2016.12.019
Fayed EA, Sabour R, Harras MF, Mehany ABM. 2019. Design, synthesis, biological evaluation and molecular modeling of new coumarin derivatives as potent anticancer agents. Medicinal Chemistry Research 28(8), 1284–1297. https://doi.org/10.1007/S00044-019-02373-X
Gabr MT, El-Gohary NS, El-Bendary ER, El-Kerdawy MM. 2017. Design, synthesis and biological evaluation of novel thiazolylcoumarin derivatives as anticancer agents. European Journal of Medicinal Chemistry 128, 36–44.
Ghufran MS, Soni P, Duddukuri GR. 2023. The global concern for cancer emergence and its prevention: A systematic unveiling of the present scenario. In Bioprospecting of tropical medicinal plants, pp. 1429–1455. https://doi.org/10.1007/978-3-031-28780-0_60
Giraldo C, Gómez S, Weinhold F, Restrepo A. 2016. Insight into the mechanism of the Michael reaction. ChemPhysChem, 2022–2034. https://doi.org/10.1002/CPHC.201600166
Govindaiah P, Dumala N, Grover P, Jaya Prakash M. 2019. Synthesis and biological evaluation of novel 4,7-dihydroxycoumarin derivatives as anticancer agents. Bioorganic and Medicinal Chemistry Letters 29(14), 1819–1824. https://doi.org/10.1016/J.BMCL.2019.05.008
Guo Y, Zhang X, Li J, Wang Z, Chen Y, Liu H. 2018. Novel nitric oxide donors of phenylsulfonylfuroxan and 3-benzyl coumarin derivatives as potent antitumor agents. ACS Medicinal Chemistry Letters 9(5), 502–506. https://doi.org/10.1021/ACSMEDCHEMLETT.8B00125
Han H, Li C, Zhang ZF, An GF. 2019. RETRACTED: Synthesis, biological evaluation and docking studies of 4-hydroxycoumarin derivatives as anti-liver cancer agents. Main Group Chemistry 18(3), 193–201. https://doi.org/10.3233/MGC-180717
Han HW, Kim HJ, Kim SY, Lee JH, Lee SJ, Kim KW. 2018. The evaluation of potent antitumor activities of shikonin coumarin-carboxylic acid, PMMB232 through HIF-1α-mediated apoptosis. Biomedicine and Pharmacotherapy 97, 656–666. https://doi.org/10.1016/J.BIOPHA.2017.10.159
Hersi F, Alkahtani HM, Alanazi AM, Aleanizy FS, Alqahtani FY, Alhoshani AR. 2020. Design and synthesis of new energy restriction mimetic agents: Potent anti-tumor activities of hybrid motifs of aminothiazoles and coumarins. Scientific Reports 10(1), 1–17. https://doi.org/10.1038/S41598-020-59685-X
Hussain MI, Syed QA, Khattak MNK, Hafez B, Reigosa MJ, El-Keblawy A. 2019. Natural product coumarins: Biological and pharmacological perspectives. Chemicke Zvesti 74(7), 863–888.
Ibrar A, Zaib S, Jabeen F, Iqbal J, Saeed A. 2016. Unraveling the alkaline phosphatase inhibition, anticancer, and antileishmanial potential of coumarin–triazolothiadiazine hybrids: Design, synthesis, and molecular docking analysis. Archiv der Pharmazie 349(7), 553–565. https://doi.org/10.1002/ARDP.201500392
Javahershenas R, Han J, Kazemi M, Jervis PJ. 2024. Recent advances in the multicomponent synthesis of heterocycles using thiosemicarbazide. ChemistrySelect 9(30). https://doi.org/10.1002/SLCT.202401496
Jones G. 2014. The Knoevenagel condensation. Organic Reactions 15, 204–599.
Kakkar S, Narasimhan B, Sharma PK, Kumar S, Kumar V. 2018. Design, synthesis and biological evaluation of 3-(2-aminooxazol-5-yl)-2H-chromen-2-one derivatives. Chemistry Central Journal 12(1), 1–13. https://doi.org/10.1186/S13065-018-0499-X
Kaur R, Bhardwaj A, Gupta S. 2023. Cancer treatment therapies: Traditional to modern approaches to combat cancers. Molecular Biology Reports 50(11), 9663–9676. https://doi.org/10.1007/S11033-023-08809-3
Kausar R, Zahoor AF, Tabassum H, Kamal S, Ahmad Bhat M. 2024. Synergistic biomedical potential and molecular docking analyses of coumarin–triazole hybrids as tyrosinase inhibitors: Design, synthesis, in vitro profiling, and in silico studies. Pharmaceuticals 17(4), 532. https://doi.org/10.3390/PH17040532
Keri RS, Sasidhar BS, Nagaraja BM, Santos MA. 2015. Recent progress in the drug development of coumarin derivatives as potent anticancer agents. European Journal of Medicinal Chemistry 100, 257–269. https://doi.org/10.1016/j.ejmech.2015.06.017
Kishkentayeva AS, Zhumagalieva AB, Abdullin KA, Nurmaganbetova ZS, Tashenova RK. 2025. Synthesis and biological evaluation of some coumarin–triazole conjugates as potential anticancer agents. Scientia Pharmaceutica 93(2), 16. https://doi.org/10.3390/SCIPHARM93020016
Koley M, Han J, Soloshonok VA, Mojumder S, Javahershenas R, Makarem A. 2024. Latest developments in coumarin-based anticancer agents: Mechanism of action and structure–activity relationship studies. RSC Medicinal Chemistry 15, 10. https://doi.org/10.1039/d3md00511a
Kontogiorgis CA, Hadjipavlou-Litina DJ. 2020. Biological evaluation of coumarin derivatives as multifunctional agents: A review. Current Medicinal Chemistry 27(7), 1090–1123.
Koparde S, Hosamani KM, Barretto DA, Joshi SD. 2018. Microwave synthesis of coumarin-maltol hybrids as potent antitumor and anti-microbial drugs: An approach to molecular docking and DNA cleavage studies. Chemical Data Collections 15–16, 41–53. https://doi.org/10.1016/J.CDC.2018.03.004
Kostova I. 2011. Synthetic and natural coumarins as cytotoxic agents. Current Medicinal Chemistry 18(24), 3929–3951.
Kumar TU, Bobde Y, Pulya S, Rangan K, Ghosh B, Bhattacharya A. 2019. Fused chromeno-thieno/furo-pyridines as potential analogs of lamellarin D and their anticancer activity evaluation. ChemistrySelect 4(36), 10726–10730. https://doi.org/10.1002/SLCT.201902946
Kurt BZ, Gazioglu I, Sonmez F, Kaplancikli ZA, Turan-Zitouni G. 2019. Synthesis, biological activity and multiscale molecular modeling studies of bis-coumarins as selective carbonic anhydrase IX and XII inhibitors with effective cytotoxicity against hepatocellular carcinoma. Bioorganic Chemistry 87, 838–850. https://doi.org/10.1016/J.BIOORG.2019.03.003
Kurt BZ, Ozten Kandas N, Dag A, Sonmez F, Kucukislamoglu M. 2020. Synthesis and biological evaluation of novel coumarin-chalcone derivatives containing urea moiety as potential anticancer agents. Arabian Journal of Chemistry 13(1), 1120–1129. https://doi.org/10.1016/J.ARABJC.2017.10.001
Lingaraju GS, Balaji KS, Jayarama S, Anil SM, Kiran KR, Sadashiva MP. 2018. Synthesis of new coumarin tethered isoxazolines as potential anticancer agents. Bioorganic and Medicinal Chemistry Letters 28(23–24), 3606–3612. https://doi.org/10.1016/J.BMCL.2018.10.046
Looker JH, McMechan JH, Mader JW. 1978. An amine solvent modification of the Kostanecki-Robinson reaction. Application to the synthesis of flavonols. Journal of Organic Chemistry 43(12), 2344–2347. https://doi.org/10.1021/JO00406A008
Lu XY, Wang ZC, Ren SZ, Shen FQ, Man RJc, Zhu HL. 2016. Coumarin sulfonamides derivatives as potent and selective COX-2 inhibitors with efficacy in suppressing cancer proliferation and metastasis. Bioorganic and Medicinal Chemistry Letters 26(15), 3491–3498.
Luo G, Zhang X, Wang Y, Li J, Liu H. 2017. Design, synthesis and biological evaluation of novel 3-substituted 4-anilino-coumarin derivatives as antitumor agents. Bioorganic and Medicinal Chemistry Letters 27(4), 867–874.
Lv N, Sun M, Liu C, Li J. 2017. Design and synthesis of 2-phenylpyrimidine coumarin derivatives as anticancer agents. Bioorganic and Medicinal Chemistry Letters 27(19), 4578–4581. https://doi.org/10.1016/J.BMCL.2017.08.044
Ma J, Huang K, Ni X, Chen R, Xu B, Wang C. 2019. Design, synthesis, biological activity and molecular docking study of coumarin derivatives bearing 2-methylbiphenyl moiety. Chemical Research in Chinese Universities 35(3), 410–417. https://doi.org/10.1007/S40242-019-8310-7
Makarov YA. 2025. Bioactive coumarins: Bioorganic strategies for targeting enzymes, receptors, and DNA. Russian Journal of Bioorganic Chemistry 51(5), 2304–2335. https://doi.org/10.1134/S1068162025601788
Mallikarjun E, Shastri LA, Holiyachi M, Samundeeswari S, Jalalpure S. 2023. Synthesis of novel anticancer coumarin-triazole-chalcone hybrids as potential AKT inhibitor. Indian Journal of Chemistry 62(11), 1162–1170. https://doi.org/10.56042/IJC.V62I11.2610
Matos MJ, Santana L, Uriarte E, Abreu OA, Molina E, Yordi EG. 2015. Coumarins—An important class of phytochemicals. In: Studies in Natural Products Chemistry, Elsevier 42, 97–140. https://doi.org/10.1016/B978-0-444-63424-5.00003-0
Matos MJ, Vazquez-Rodriguez S, Fonseca A, Uriarte E, Santana L, Borges F. 2017. Heterocyclic antioxidants in nature: Coumarins. Current Topics in Medicinal Chemistry 21(4), 311–324. https://doi.org/10.2174/1385272820666161017170652
Mattiuzzi C, Lippi G. 2019. Current cancer epidemiology. Journal of Epidemiology and Global Health 9(4), 217–222. https://doi.org/10.2991/JEGH.K.191008.001
Menteşe E, Güner A, Polatlı E, Emirik M, Bektaş H, Kahveci B. 2021. Synthesis and anticancer activities of some new coumarin derivatives including the triazole ring and their in silico molecular docking studies. Archiv der Pharmazie 354(3), 2000284. https://doi.org/10.1002/ARDP.202000284
Mohamed KS, Elbialy EE. 2018. Synthesis, characterization, and cytotoxicity evaluation of some new benzo[f]coumarin derivatives. Journal of Heterocyclic Chemistry 55(4), 893–898. https://doi.org/10.1002/JHET.3115
Mohamed TK, Batran RZ, Elseginy SA, Ali MM, Mahmoud AE. 2019. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis. Bioorganic Chemistry 85, 253–273. https://doi.org/10.1016/J.BIOORG.2018.12.040
Murray RDH, Mendez J, Brown SA. 1982. The natural coumarins: Occurrence, chemistry and biochemistry. Wiley.
Patel M, Patel K. 2019. Naphthalene substituted benzo[c]coumarins: Synthesis, characterization and evaluation of antibacterial activity and cytotoxicity. Heterocyclic Communications 25(1), 146–151. https://doi.org/10.1515/HC-2019-0024
Pavić K, Beus M, Poje G, Uzelac L, Kralj M, Rajić Z. 2021. Synthesis and biological evaluation of harmirins, novel harmine–coumarin hybrids as potential anticancer agents. Molecules 26(21), 6490. https://doi.org/10.3390/MOLECULES26216490
Prateeptongkum S, Mahavorasirikul W, Duangdee N. 2018. Synthesis and anti-proliferative activity of novel oxepin-annulated coumarins. Arkivoc 2018(7), 73–85. https://doi.org/10.24820/ARK.5550190.P010.547
Putri DEK, Wahyuni FS, Dachriyanus, Zaini MA, Arbain D. 2022. The predicted models of anti-colon cancer and anti-hepatoma activities of substituted 4-anilino coumarin derivatives using quantitative structure-activity relationship (QSAR). Journal of King Saud University – Science 34(3), 101837. https://doi.org/10.1016/J.JKSUS.2022.101837
Rohini R, Reddy PM, Shanker K, Hu A, Ravinder V. 2015. Antimicrobial and anticancer activities of coumarin derivatives: A review. European Journal of Medicinal Chemistry 101, 1–14.
Sashidhara KV, Kumar M, Khedkar SA, Kumar A, Singh P, Saxena AK. 2016. Design, synthesis and in vitro evaluation of coumarin–imidazo[1,2-a]pyridine derivatives against cancer induced osteoporosis. RSC Advances 6(83), 80037–80048. https://doi.org/10.1039/C6RA15674F
Sharma D, Kumar S, Narasimhan B. 2023. Recent methods for synthesis of coumarin derivatives and their biological activities. Current Organic Chemistry 27(5), 452–470. https://doi.org/10.2174/1385272826666220914123456
Shen FQ, Wang J, Wang Y, Liu H, Zhang X. 2017. Synthesis of novel hybrids of pyrazole and coumarin as dual inhibitors of COX-2 and 5-LOX. Bioorganic and Medicinal Chemistry Letters 27(16), 3653–3660. https://doi.org/10.1016/J.BMCL.2017.07.020
Sinha S, Kumaran AP, Mishra D, Paira P. 2016. Synthesis and cytotoxicity study of novel 3-(triazolyl)coumarins based fluorescent scaffolds. Bioorganic and Medicinal Chemistry Letters 26(22), 5557–5561. https://doi.org/10.1016/J.BMCL.2016.09.078
Soni R, Umar S, Shah NN, Balkrishnan S, Soman SS. 2017. Design, synthesis, and anticancer activity of 3H-benzo[f]chromen-3-one derivatives. Journal of Heterocyclic Chemistry 54(4), 2501–2510. https://doi.org/10.1002/JHET.2853
Sriharikrishnaa S, Suresh PS, Prasada KS. 2023. An introduction to fundamentals of cancer biology. In: Cancer Biology and Advances in Treatment, Springer, 307–330. https://doi.org/10.1007/978-3-031-31852-8_11
Stadler M, Hellwig V. 2004. PCR-based data and secondary metabolites as chemotaxonomic markers in high-throughput screening for bioactive compounds from fungi. In Handbook of industrial mycology, pp. 288–327. https://doi.org/10.1201/9780203970553-13
Stefanachi A, Leonetti F, Pisani L, Catto M, Carotti A. 2018. Coumarin: A natural privileged scaffold for medicinal chemistry. Molecules 23(2), 250.
Talhi O, Silva AMS, Cavaleiro JAS. 2000. Natural product-like combinatorial libraries based on privileged structures. 1. General principles and solid-phase synthesis of benzopyrans. Journal of the American Chemical Society 122(41), 9939–9953.
Tangella Y, Singh SP, Vishwakarma RA, Bharate SB. 2017. An efficient one-pot approach for the regio- and diastereoselective synthesis of trans-dihydrofuran derivatives: Cytotoxicity and DNA-binding studies. Organic and Biomolecular Chemistry 15, 6837. https://doi.org/10.1039/c7ob01456b
Thakur A, Singla R, Jaitak V. 2015. Coumarins as anticancer agents: A review on synthetic strategies, mechanism of action and SAR studies. European Journal of Medicinal Chemistry.
Tiwari AK, Singh MV. 2023. Insights into the origin and therapeutic implications of benzopyran and its derivatives. ChemistrySelect 8(20). https://doi.org/10.1002/SLCT.202300220
Torre D. 2023. Causes of cancer and mechanisms of carcinogenesis. In Understanding cancer: From mechanisms to therapeutics, pp. 229–279.
Vaarla K, Reddy YT, Reddy PN, Reddy VM. 2019. 3-(2-(5-Amino-3-aryl-1H-pyrazol-1-yl) thiazol-4-yl)-2H-chromen-2-ones as potential anticancer agents: Synthesis, anticancer activity evaluation and molecular docking studies. ChemistrySelect 4(7), 2193–2200.
Vagish CB, Kumara K, Vivek HK, Bharath S, Lokanath NK, Ajay Kumar K. 2021. Coumarin-triazole hybrids: Design, microwave-assisted synthesis, crystal and molecular structure, theoretical and computational studies and screening for their anticancer potentials against PC-3 and DU-145. Journal of Molecular Structure 1230, 129899. https://doi.org/10.1016/J.MOLSTRUC.2021.129899
Venkatachalam H, Kumaravel S. 2019. The oxygen-containing fused heterocyclic compounds. In: Heterocyclic Chemistry, IntechOpen. https://doi.org/10.5772/intechopen.84666
Venugopala KN, Rashmi V, Odhav B. 2013. Review on natural coumarin lead compounds for their pharmacological activity. BioMed Research International 2013, 963248. https://doi.org/10.1155/2013/963248
Wang Y, Zhang W, Dong J, Gao J. 2020. Design, synthesis and bioactivity evaluation of coumarin-chalcone hybrids as potential anticancer agents. Bioorganic Chemistry 95, 103530. https://doi.org/10.1016/J.BIOORG.2019.103530
Watson HB. 1941. Mechanism of the addition and condensation reactions of carbonyl compounds. Transactions of the Faraday Society 37, 707–713. https://doi.org/10.1039/TF9413700707
Williams GH, Stoeber K. 2012. The cell cycle and cancer. Journal of Pathology 226(2), 352–364. https://doi.org/10.1002/path.3022
Yagawa Y, Tanigawa K, Kobayashi Y, Yamamoto T, Okajima K. 2017. Cancer immunity and therapy using hyperthermia with immunotherapy, radiotherapy, chemotherapy, and surgery. Journal of Cancer Metastasis and Treatment 3, 218–248.
Yang L, Wang Y, Li J, Zhang X, Liu H. 2017. 2017. Dual functional small molecule fluorescent probes for image-guided estrogen receptor-specific targeting coupled potent antiproliferative potency for breast cancer therapy. Bioorganic and Medicinal Chemistry 25(13), 3531–3539.
Zafar SN, Shah AA, Hashmi ZG, Haider AH, Zogg CK, Schneider EB. 2019. Patient care management of cancer. World Journal of Surgery 43(9), 2203–2210.
Zengin Kurt B, Sonmez F, Ozturk D, Akdemir A, Angeli A, Supuran CT. 2019. Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies. European Journal of Medicinal Chemistry 183, 111702.
Mohd Akil, Chandra Shekhar Yadav, Atul Krishna, Vijay Kumar Verma, Iqbal Azad*, Tridev Katiyar, Amar Chandra Sharma, Mirza Masroor Ali Beg, 2026. Recent findings on the anticancer potential of coumarin hybrid derivatives. Int. J. Biosci., 28(3), 52-79.
Copyright © 2026 by the Authors. This article is an open access article and distributed under the terms and conditions of the Creative Commons Attribution 4.0 (CC BY 4.0) license.